H
Henning T. Mouridsen
Researcher at University of Copenhagen
Publications - 121
Citations - 16119
Henning T. Mouridsen is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Breast cancer & Tamoxifen. The author has an hindex of 52, co-authored 120 publications receiving 15464 citations. Previous affiliations of Henning T. Mouridsen include Copenhagen University Hospital & The Breast Cancer Research Foundation.
Papers
More filters
Journal ArticleDOI
Vinorelbine as first-line or second-line therapy for advanced breast cancer: a Phase I-II trial by the Danish Breast Cancer Co-operative Group.
Sven Tyge Langkjer,Bent Ejlertsen,Henning T. Mouridsen,Jørn Andersen,Mette Møller Nielsen,Knud Age Møller,Madsen El,Vera Haarh +7 more
TL;DR: The maximum tolerated dose of intravenous vinorelbine was established and the determined dose to assess efficacy and safety in patients with metastatic breast cancer previously treated with epirubicin was determined to achieve low subjective burdens of toxicity.
Journal ArticleDOI
Clinical and Histopathological Prognostic Factors in Chondrosarcomas
Søren Daugaard,Olaf Myhre-Jensen,Torben Schiødt,Anne Grethe Jurik,Johnny Keller,Henning T. Mouridsen,Bjarne Lund +6 more
TL;DR: Although the grading of chondrosarcomas is in need of improvement, its replacement by semiquantitative evaluation of individual histopathological parameters as performed in this study offers no advantage.
Journal ArticleDOI
Prognostic significance of residual cancer tissue after diagnostic biopsy in breast carcinoma. Three-year short-term results
TL;DR: A significantly higher cumulative recurrence rate within 3 yr was found in cases with residual cancer compared to cases without this finding, and the difference was most pronounced in the premenopausal high-risk group.
Journal ArticleDOI
A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.
Lars Bastholt,Carl-Johan Johansson,Per Pfeiffer,Leif Svensson,Sven-Åke Johansson,Per Olov Gunnarsson,Henning T. Mouridsen +6 more
TL;DR: It is found that the elimination phase of chlorambucil and PAM in plasma is prolonged after the administration of prednimustine as compared with chlorambukil per se, and the modified plasma profile of the alkylating components following prednIMustine administration may be important for the clinical efficacy ofprednimUSTine.
Journal ArticleDOI
Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.
Henning T. Mouridsen,Per Eystein Lønning,Matthias W Beckmann,Kimberly L. Blackwell,Julie Doughty,Joseph Gligorov,Antonio Llombart-Cussac,André Robidoux,Beat Thürlimann,Michael Gnant +9 more
TL;DR: The proceedings from an Expert Panel meeting of regionally diverse breast cancer specialists regarding the appropriate use of aromatase inhibitors in postmenopausal hormone-responsive early breast cancer and bisphosphonates as anticancer therapy in adjuvant breast cancer are outlined.